CASI: CASI Pharmaceuticals, Inc. Stock

SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)

Valuation
Market Cap ($M) 32.60
Enterprise Value ($M) 56.06
Book Value ($M) 24.16
Book Value / Share 1.86
Price / Book 1.35
NCAV ($M) 8.24
NCAV / Share 0.63
Price / NCAV 3.96

Profitability (mra)
Return on Invested Capital (ROIC) -0.59
Return on Assets (ROA) -0.30
Return on Equity (ROE) -0.43

Liquidity (mrq)
Quick Ratio 2.60
Current Ratio 3.55

Balance Sheet (mrq) ($M)
Current Assets 59.34
Assets 75.27
Liabilities 51.10
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 33.88
Operating Income -25.28
Net Income -26.94
Earnings Per Share Basic And Diluted n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -19.97
Cash from Investing -9.67
Cash from Financing -0.91

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
02-20 13D/A Sparkle Byte Ltd 7.60 -90.00
01-26 13G/A Huang James 19.99
2023-04-18 13D/A He Wei-Wu 19.75

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-04-24 860 8,839 9.73
2024-04-23 1,043 3,267 31.93
2024-04-22 3,727 1,507 247.31
2024-04-19 2,240 1,154 194.11

(click for more detail)

Similar Companies
BYSI – BeyondSpring Inc. CALC – CalciMedica, Inc.
CAPR – Capricor Therapeutics, Inc. CDIO – Cardio Diagnostics Holdings, Inc.
CDMO – Avid Bioservices, Inc.


Financial data and stock pages provided by
Fintel.io